MR/TRUS Fusion Guided Prostate Biopsy

  • End date
    Dec 23, 2021
  • participants needed
  • sponsor
    Icahn School of Medicine at Mount Sinai
Updated on 23 January 2021
prostate biopsy
transrectal ultrasound


This study will determine if targeted (Magnetic Resonance (MR) / Ultrasound (US) fusion biopsy) plus conventional biopsy is superior to conventional biopsy alone in diagnosing subjects with prostate cancer.


The efficacy of targeting lesions for surgery may be limited by the visibility of a target during the procedure. The successful outcome of surgical intervention depends upon accurate device placement, which may be very challenging in certain settings, such as when a kidney tumor only is visible for a brief moment during the transient arterial phase of a contrast injection, and soon disappearing on dynamic imaging.

Historically, prostate cancer was diagnosed by digitally guided trans-rectal prostate biopsies. With PSA (Prostate Specific Antigen) screening and improvements in ultrasonography, trans-rectal ultrasound (TRUS) guided prostate biopsy have become the standard of care to screen and diagnose localized prostate cancer. Standard US 12-14 core prostate biopsy is now common practice, detecting cancer in 27% to 44% of patients.

Prostate MR imaging at 3 Tesla magnet dramatically improves diagnostic utility dramatically but biopsies are difficult, time-consuming, and require specialized equipment, which increases the cost significantly.

To meet this challenge TRUS images are overlaid on a previously obtained prostate MRI, combined with an electromagnetic tracking system. The urologist then performs directed prostate biopsies at MR-identified targets in addition to the standard prostate biopsies.

This study will consist of comparison of the standard of care prostate biopsy with the protocol biopsy which consists of a US guided prostate biopsy and a MR/US fusion tracked prostate biopsy. Each patient will act as their own control.

Condition Prostatic disorder, Prostate Disorders, Elevated Prostate Specific Antigen, Family History of Prostate Cancer, Positive Digital Rectal Exam
Treatment Prostate Biopsy, MR US Fusion Guided Prostate Biopsy, MR/TRUS Fusion Guided Prostate Biopsy
Clinical Study IdentifierNCT04026763
SponsorIcahn School of Medicine at Mount Sinai
Last Modified on23 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Are you male?
Do you have any of these conditions: Elevated Prostate Specific Antigen or Prostatic disorder or Family History of Prostate Cancer or Positive Digital Rectal Exam?
Do you have any of these conditions: Positive Digital Rectal Exam or Prostate Disorders or Elevated Prostate Specific Antigen or Prostatic disorder or Family History of Prostate Cancer?
All patients must have a pre-operative MRI performed in accordance with the MT Sinai/NIH MR prostate imaging guidelines
Age greater than 18 years
No serious concurrent medical illness that would preclude the patient from making a rational informed decision on participation
The ability to understand and willingness to sign a written informed consent form, and to comply with the protocol. If in question, an ethics consult will be obtained
Ability to tolerate sedation and or general anesthesia if required
PSA >2.5 or Abnormal digital rectal exam or current recommendations for biopsy from the American Urological Association
Pre-biopsy prostate MRI as described above, showing targetable lesions within 4 months of biopsy
Able to tolerate a ultrasound guided biopsy

Exclusion Criteria

Patients with an altered mental status that precludes understanding or consenting for the biopsy procedure will be excluded from this study
Patients unlikely able to hold reasonably still on a procedure table for the length of the procedure
Patients with pacemakers or automatic implantable cardiac defibrillators (contraindications to MRI)
Patients with uncorrectable coagulopathies
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note